{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:17:41Z","timestamp":1785370661555,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T00:00:00Z","timestamp":1445472000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12906-015-0825-y","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T17:33:35Z","timestamp":1445535215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Inhibitory effect of curcumin on testosterone induced benign prostatic hyperplasia rat model"],"prefix":"10.1186","volume":"15","author":[{"given":"Su Kang","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosik","family":"Seok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Jeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Sook","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Cheol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooil","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Yeol","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hyub","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ock","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Ho","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,22]]},"reference":[{"issue":"4","key":"825_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4111\/kju.2012.53.4.263","volume":"53","author":"YJ Lee","year":"2012","unstructured":"Lee YJ, Jeong SJ, Byun SS, Lee JJ, Han JW, Kim KW. Prevalence and correlates of nocturia in community-dwelling older men: results from the korean longitudinal study on health and aging. Korean J Urol. 2012;53(4):263\u20137.","journal-title":"Korean J Urol"},{"issue":"3","key":"825_CR2","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s11255-008-9333-z","volume":"40","author":"H Nandeesha","year":"2008","unstructured":"Nandeesha H. Benign prostatic hyperplasia: dietary and metabolic risk factors. Int Urol Nephrol. 2008;40(3):649\u201356.","journal-title":"Int Urol Nephrol"},{"key":"825_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1749-6632.2009.04115.x","volume":"1155","author":"YS Zhu","year":"2009","unstructured":"Zhu YS, Imperato-McGinley JL. 5alpha-reductase isozymes and androgen actions in the prostate. Ann N Y Acad Sci. 2009;1155:43\u201356.","journal-title":"Ann N Y Acad Sci"},{"issue":"4 Suppl 1","key":"825_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0090-4295(03)00045-1","volume":"61","author":"C Carson 3rd","year":"2003","unstructured":"Carson 3rd C, Rittmaster R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology. 2003;61(4 Suppl 1):2\u20137.","journal-title":"Urology"},{"issue":"1","key":"825_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1439-0272.1998.tb01375.x","volume":"30","author":"MC Uygur","year":"1998","unstructured":"Uygur MC, Gur E, Arik AI, Altug U, Erol D. Erectile dysfunction following treatments of benign prostatic hyperplasia: a prospective study. Andrologia. 1998;30(1):5\u201310.","journal-title":"Andrologia"},{"issue":"4","key":"825_CR6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ncpuro1060","volume":"5","author":"AK Patel","year":"2008","unstructured":"Patel AK, Chapple CR. Medical management of lower urinary tract symptoms in men: current treatment and future approaches. Nat Clin Pract Urol. 2008;5(4):211\u20139.","journal-title":"Nat Clin Pract Urol"},{"issue":"8","key":"825_CR7","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/bph.12131","volume":"169","author":"BB Aggarwal","year":"2013","unstructured":"Aggarwal BB, Gupta SC, Sung B. Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br J Pharmacol. 2013;169(8):1672\u201392.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"825_CR8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.clnu.2013.09.012","volume":"33","author":"A Sahebkar","year":"2013","unstructured":"Sahebkar A. A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels. Clin Nutr. 2013;33(3):406\u201314.","journal-title":"Clin Nutr"},{"issue":"10","key":"825_CR9","first-page":"1131","volume":"12","author":"TA Nguyen","year":"2013","unstructured":"Nguyen TA, Friedman AJ. Curcumin: a novel treatment for skin-related disorders. J Drugs Dermatol. 2013;12(10):1131\u20137.","journal-title":"J Drugs Dermatol"},{"issue":"9","key":"825_CR10","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/mnfr.201200718","volume":"57","author":"LL Wang","year":"2013","unstructured":"Wang LL, Sun Y, Huang K, Zheng L. Curcumin, a potential therapeutic candidate for retinal diseases. Mol Nutr Food Res. 2013;57(9):1557\u201368.","journal-title":"Mol Nutr Food Res"},{"key":"825_CR11","doi-asserted-by":"crossref","unstructured":"Chiu S, Terpstra KJ, Bureau Y, Hou J, Raheb H, Cernvosky Z, et al. Liposomal-formulated curcumin [Lipocurc] targeting HDAC (Histone Deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson\u2019s disease: implications for epigenetics-based nanotechnologydriven drug platform. J Complement Integr Med. 2013;10(1):75-88.","DOI":"10.1515\/jcim-2013-0020"},{"issue":"1","key":"825_CR12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.redox.2013.09.003","volume":"1","author":"J Trujillo","year":"2013","unstructured":"Trujillo J, Chirino YI, Molina-Jijon E, Anderica-Romero AC, Tapia E, Pedraza-Chaverri J. Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biol. 2013;1(1):448\u201356.","journal-title":"Redox Biol"},{"key":"825_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2013.07.007","volume":"65C","author":"Y Yang","year":"2013","unstructured":"Yang Y, Duan W, Lin Y, Yi W, Liang Z, Yan J, et al. SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury. Free Radic Biol Med. 2013;65C:667\u201379.","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"825_CR14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.phymed.2013.03.022","volume":"20","author":"N Okudan","year":"2013","unstructured":"Okudan N, Belviranli M, Gokbel H, Oz M, Kumak A. Protective effects of curcumin supplementation on intestinal ischemia reperfusion injury. Phytomedicine. 2013;20(10):844\u20138.","journal-title":"Phytomedicine"},{"issue":"4","key":"825_CR15","first-page":"318","volume":"29","author":"JH Zhou","year":"2013","unstructured":"Zhou JH, Hao ML, Zhao S, Chen HE, Chen D, Ying L, et al. [Effects of curcumin on pneumocyte apoptosis and CHOP in pulmonary ischemia\/reperfusion injury of mice]. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2013;29(4):318\u201323.","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"issue":"1","key":"825_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s13273-015-0004-8","volume":"11","author":"G-Z Zhou","year":"2015","unstructured":"Zhou G-Z, Sun G-C, Zhang S-N. Curcumin derivative HBC induces autophagy through activating AMPK signal in A549 cancer cells. Molecular Cellular Toxicol. 2015;11(1):29\u201334.","journal-title":"Molecular Cellular Toxicol"},{"issue":"8","key":"825_CR17","doi-asserted-by":"publisher","first-page":"904","DOI":"10.2174\/187152009789124655","volume":"9","author":"Q Shi","year":"2009","unstructured":"Shi Q, Shih CC, Lee KH. Novel anti-prostate cancer curcumin analogues that enhance androgen receptor degradation activity. Anticancer Agents Med Chem. 2009;9(8):904\u201312.","journal-title":"Anticancer Agents Med Chem"},{"issue":"6","key":"825_CR18","first-page":"431","volume":"68","author":"H Guo","year":"2013","unstructured":"Guo H, Xu YM, Ye ZQ, Yu JH, Hu XY. Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IkappaBalpha, c-Jun and androgen receptor. Pharmazie. 2013;68(6):431\u20134.","journal-title":"Pharmazie"},{"issue":"3","key":"825_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1530\/JOE-12-0207","volume":"214","author":"B Shan","year":"2012","unstructured":"Shan B, Schaaf C, Schmidt A, Lucia K, Buchfelder M, Losa M, et al. Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas. J Endocrinol. 2012;214(3):389\u201398.","journal-title":"J Endocrinol"},{"issue":"6","key":"825_CR20","first-page":"1557","volume":"15","author":"MK Bae","year":"2006","unstructured":"Bae MK, Kim SH, Jeong JW, Lee YM, Kim HS, Kim SR, et al. Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1. Oncol Rep. 2006;15(6):1557\u201362.","journal-title":"Oncol Rep"},{"issue":"1","key":"825_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbadis.2012.09.002","volume":"1832","author":"HJ Kim","year":"2013","unstructured":"Kim HJ, Park JW, Cho YS, Cho CH, Kim JS, Shin HW, et al. Pathogenic role of HIF-1alpha in prostate hyperplasia in the presence of chronic inflammation. Biochim Biophys Acta. 2013;1832(1):183\u201394.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"825_CR22","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3109\/14756360903555274","volume":"25","author":"HS Lee","year":"2010","unstructured":"Lee HS, Lee MJ, Kim H, Choi SK, Kim JE, Moon HI, et al. Curcumin inhibits TNFalpha-induced lectin-like oxidised LDL receptor-1 (LOX-1) expression and suppresses the inflammatory response in human umbilical vein endothelial cells (HUVECs) by an antioxidant mechanism. J Enzyme Inhib Med Chem. 2010;25(5):720\u20139.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1 Suppl 4","key":"825_CR23","first-page":"17","volume":"54","author":"A Ledda","year":"2012","unstructured":"Ledda A, Belcaro G, Dugall M, Luzzi R, Scoccianti M, Togni S, et al. Meriva(R), a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a pilot, product evaluation registry study. Panminerva Med. 2012;54(1 Suppl 4):17\u201322.","journal-title":"Panminerva Med"},{"issue":"7","key":"825_CR24","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1073\/pnas.1222355110","volume":"110","author":"FG Rick","year":"2013","unstructured":"Rick FG, Abi-Chaker A, Szalontay L, Perez R, Jaszberenyi M, Jayakumar AR, et al. Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist. Proc Natl Acad Sci U S A. 2013;110(7):2617\u201322.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"825_CR25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/jemt.20740","volume":"72","author":"LS Corradi","year":"2009","unstructured":"Corradi LS, Goes RM, Vilamaior PS, Taboga SR. Increased androgen receptor and remodeling in the prostatic stroma after the inhibition of 5-alpha reductase and aromatase in gerbil ventral prostate. Microsc Res Tech. 2009;72(12):939\u201350.","journal-title":"Microsc Res Tech"},{"issue":"10","key":"825_CR26","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1210\/me.2013-1207","volume":"27","author":"KP Lai","year":"2013","unstructured":"Lai KP, Huang CK, Fang LY, Izumi K, Lo CW, Wood R, et al. Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH). Mol Endocrinol. 2013;27(10):1617\u201331.","journal-title":"Mol Endocrinol"},{"issue":"4","key":"825_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1159\/000020181","volume":"37","author":"G Bartsch","year":"2000","unstructured":"Bartsch G, Rittmaster RS, Klocker H. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. Eur Urol. 2000;37(4):367\u201380.","journal-title":"Eur Urol"},{"issue":"2","key":"825_CR28","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.gene.2013.10.042","volume":"534","author":"Y Chen","year":"2013","unstructured":"Chen Y, Li T, Yu X, Li J, Luo D, Mo Z, et al. The RTK\/ERK pathway is associated with prostate cancer risk on the SNP level: A pooled analysis of 41 sets of data from case\u2013control studies. Gene. 2013;534(2):286\u201397.","journal-title":"Gene"},{"issue":"2","key":"825_CR29","first-page":"305","volume":"29","author":"N Soulitzis","year":"2006","unstructured":"Soulitzis N, Karyotis I, Delakas D, Spandidos DA. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia. Int J Oncol. 2006;29(2):305\u201314.","journal-title":"Int J Oncol"},{"issue":"2","key":"825_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.canlet.2011.08.034","volume":"318","author":"P Fuzio","year":"2012","unstructured":"Fuzio P, Ditonno P, Rutigliano M, Battaglia M, Bettocchi C, Loverre A, et al. Regulation of TGF-beta1 expression by androgen deprivation therapy of prostate cancer. Cancer Lett. 2012;318(2):135\u201344.","journal-title":"Cancer Lett"},{"issue":"7","key":"825_CR31","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/pros.21289","volume":"71","author":"FG Rick","year":"2011","unstructured":"Rick FG, Schally AV, Block NL, Halmos G, Perez R, Fernandez JB, et al. LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia. Prostate. 2011;71(7):736\u201347.","journal-title":"Prostate"},{"issue":"3","key":"825_CR32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s12032-013-0674-9","volume":"30","author":"S Yu","year":"2013","unstructured":"Yu S, Xia S, Yang D, Wang K, Yeh S, Gao Z, et al. Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion. Med Oncol. 2013;30(3):674.","journal-title":"Med Oncol"},{"issue":"4\u20135","key":"825_CR33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.diff.2011.06.001","volume":"82","author":"ID McLaren","year":"2011","unstructured":"McLaren ID, Jerde TJ, Bushman W. Role of interleukins, IGF and stem cells in BPH. Differentiation. 2011;82(4\u20135):237\u201343.","journal-title":"Differentiation"},{"issue":"6","key":"825_CR34","first-page":"413","volume":"11","author":"JC Shao","year":"2005","unstructured":"Shao JC, Wang Y, Zhang SW, Luo DK, Chang DG, Wu XQ, et al. [Angiogenesis and regulatory factors in rats with BPH induced by testosterone]. Zhonghua Nan Ke Xue. 2005;11(6):413\u20138.","journal-title":"Zhonghua Nan Ke Xue"},{"issue":"5","key":"825_CR35","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1248\/bpb.35.737","volume":"35","author":"S Niwa","year":"2012","unstructured":"Niwa S, Ohya S, Kojima Y, Sasaki S, Yamamura H, Sakuragi M, et al. Down-regulation of the large-conductance Ca(2+)-activated K+ channel, K(Ca)1.1 in the prostatic stromal cells of benign prostate hyperplasia. Biol Pharm Bull. 2012;35(5):737\u201344.","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"825_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/08977190600976501","volume":"24","author":"NA Cross","year":"2006","unstructured":"Cross NA, Reid SV, Harvey AJ, Jokonya N, Eaton CL. Opposing actions of TGFbeta1 and FGF2 on growth, differentiation and extracellular matrix accumulation in prostatic stromal cells. Growth Factors. 2006;24(4):233\u201341.","journal-title":"Growth Factors"},{"issue":"2 Pt 2","key":"825_CR37","doi-asserted-by":"publisher","first-page":"E23","DOI":"10.1111\/j.1464-410X.2010.09699.x","volume":"108","author":"A Descazeaud","year":"2011","unstructured":"Descazeaud A, Weinbreck N, Robert G, Vacherot F, Abbou CC, Labrousse F, et al. Transforming growth factor beta-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation. BJU Int. 2011;108(2 Pt 2):E23\u20138.","journal-title":"BJU Int"},{"issue":"3","key":"825_CR38","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1210\/en.2006-1272","volume":"148","author":"DL Kleinberg","year":"2007","unstructured":"Kleinberg DL, Ruan W, Yee D, Kovacs KT, Vidal S. Insulin-like growth factor (IGF)-I controls prostate fibromuscular development: IGF-I inhibition prevents both fibromuscular and glandular development in eugonadal mice. Endocrinology. 2007;148(3):1080\u20138.","journal-title":"Endocrinology"},{"issue":"3","key":"825_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1139\/cjpp-2012-0267","volume":"91","author":"V Youreva","year":"2013","unstructured":"Youreva V, Kapakos G, Srivastava AK. Insulin-like growth-factor-1-induced PKB signaling and Egr-1 expression is inhibited by curcumin in A-10 vascular smooth muscle cells. Can J Physiol Pharmacol. 2013;91(3):241\u20137.","journal-title":"Can J Physiol Pharmacol"},{"issue":"9","key":"825_CR40","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1139\/y2012-059","volume":"90","author":"G Kapakos","year":"2012","unstructured":"Kapakos G, Youreva V, Srivastava AK. Attenuation of endothelin-1-induced PKB and ERK1\/2 signaling, as well as Egr-1 expression, by curcumin in A-10 vascular smooth muscle cells. Can J Physiol Pharmacol. 2012;90(9):1277\u201385.","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"825_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/biof.1068","volume":"39","author":"A Shehzad","year":"2013","unstructured":"Shehzad A, Lee J, Lee YS. Curcumin in various cancers. Biofactors. 2013;39(1):56\u201368.","journal-title":"Biofactors"},{"issue":"12","key":"825_CR42","doi-asserted-by":"publisher","first-page":"e53329","DOI":"10.1371\/journal.pone.0053329","volume":"7","author":"P Xie","year":"2012","unstructured":"Xie P, Zhang W, Yuan S, Chen Z, Yang Q, Yuan D, et al. Suppression of experimental choroidal neovascularization by curcumin in mice. PLoS One. 2012;7(12):e53329.","journal-title":"PLoS One"},{"issue":"4","key":"825_CR43","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4196\/kjpp.2013.17.4.267","volume":"17","author":"YJ Cho","year":"2013","unstructured":"Cho YJ, Yi CO, Jeon BT, Jeong YY, Kang GM, Lee JE, et al. Curcumin attenuates radiation-induced inflammation and fibrosis in rat lungs. Korean J Physiol Pharmacol. 2013;17(4):267\u201374.","journal-title":"Korean J Physiol Pharmacol"},{"issue":"4","key":"825_CR44","doi-asserted-by":"publisher","first-page":"e62300","DOI":"10.1371\/journal.pone.0062300","volume":"8","author":"G Kim","year":"2013","unstructured":"Kim G, Jang MS, Son YM, Seo MJ, Ji SY, Han SH, et al. Curcumin inhibits CD4(+) T cell activation, but augments CD69 expression and TGF-beta1-mediated generation of regulatory T cells at late phase. PLoS One. 2013;8(4):e62300.","journal-title":"PLoS One"},{"issue":"3","key":"825_CR45","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/imm.12079","volume":"139","author":"A Jacob","year":"2013","unstructured":"Jacob A, Chaves L, Eadon MT, Chang A, Quigg RJ, Alexander JJ. Curcumin alleviates immune-complex-mediated glomerulonephritis in factor-H-deficient mice. Immunology. 2013;139(3):328\u201337.","journal-title":"Immunology"},{"issue":"1","key":"825_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/biof.1066","volume":"39","author":"A Shehzad","year":"2013","unstructured":"Shehzad A, Rehman G, Lee YS. Curcumin in inflammatory diseases. Biofactors. 2013;39(1):69\u201377.","journal-title":"Biofactors"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-015-0825-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-015-0825-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-015-0825-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T20:21:16Z","timestamp":1567282876000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-015-0825-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,22]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["825"],"URL":"https:\/\/doi.org\/10.1186\/s12906-015-0825-y","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,22]]},"article-number":"380"}}